Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Country Life Vitamins Inks Joint Venture Agreement With Kikkoman
Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide.
- Country Life Vitamins Inks Joint Venture Agreement With Kikkoman
Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide.
- Technology Flavors & Fragrances, Inc. Reports Fourth Quarter and 2004 Results
Company reports Q4 sales drop from $3,465,000 to $3,042,000, while gross profit increased to 37.5% from 36.7%, company reports net loss of $921,000, ($.07 per fully diluted share), compared to a net loss of $403,000 ($.03 per fully diluted share) in last year's fourth quarter.
- Technology Flavors & Fragrances, Inc. Reports Fourth Quarter and 2004 Results
Company reports Q4 sales drop from $3,465,000 to $3,042,000, while gross profit increased to 37.5% from 36.7%, company reports net loss of $921,000, ($.07 per fully diluted share), compared to a net loss of $403,000 ($.03 per fully diluted share) in last year's fourth quarter.
- Japanese Dietary Supplement Market Expands
Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004.
- Japanese Dietary Supplement Market Expands
Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004.
- Japanese Dietary Supplement Market Expands
Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004.
- Japanese Dietary Supplement Market Expands
Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004.
- Japanese Dietary Supplement Market Expands
Japanese dietary supplement market expands based on a survey by Statistics Bureau of the Japanese Ministry of International Affairs and Communications reporting the results of its Family Income and Expenditure Survey of 2004.
- Nutrition 21 Raises $9.6 Million In Convertible Preferred Stock Financing
Company has privately placed 9,600 shares of preferred stock and 2,948,662 warrants for an aggregate purchase price of $9.6 million.
- Nutrition 21 Raises $9.6 Million In Convertible Preferred Stock Financing
Company has privately placed 9,600 shares of preferred stock and 2,948,662 warrants for an aggregate purchase price of $9.6 million.
- Weider Announces Fiscal 2005 Third Quarter Results
Company reports net sales of $65.6 million for Q3, compared to $67.5 million prior year, net income was $1.2 million, or $0.05 per share, compared to $2.6 million, or $0.10 per share the previous year. The company attributes decrease in sales to domestic private label sales and weakness in its Haleko business unit's Multipower and Multaben brands.
In other news, the company announced the sale of assets of its Active Nutrition Unit to Weider Global Nutrition for $14.0 million.
- Weider Announces Fiscal 2005 Third Quarter Results
Company reports net sales of $65.6 million for Q3, compared to $67.5 million prior year, net income was $1.2 million, or $0.05 per share, compared to $2.6 million, or $0.10 per share the previous year. The company attributes decrease in sales to domestic private label sales and weakness in its Haleko business unit's Multipower and Multaben brands.
In other news, the company announced the sale of assets of its Active Nutrition Unit to Weider Global Nutrition for $14.0 million.
- Phillips Health, LLC Announces Company Name Change to Healthy Directions, LLC
Name change to Healthy Directions, LLC, effective immediately.
- Phillips Health, LLC Announces Company Name Change to Healthy Directions, LLC
Name change to Healthy Directions, LLC, effective immediately.
- Great Spirit Ventures Acquires The Natural Dentist (R)
Great Spirit Ventures, LLC has acquired The Natural Dentist(R), adding company to its portfolio of companies addressing health and wellness.
- Great Spirit Ventures Acquires The Natural Dentist (R)
Great Spirit Ventures, LLC has acquired The Natural Dentist(R), adding company to its portfolio of companies addressing health and wellness.
- NutraCea(R) Executes Definitive Agreement to Merge with RiceX
Companies sign definitive agreement to merge with a newly formed subsidiary of NutraCea merging into RiceX, RiceX becoming a wholly owned subsidiary of NutraCea, and the shareholders of RiceX to receive shares of NutraCea common stock in exchange for RiceX shares.
- NutraCea(R) Executes Definitive Agreement to Merge with RiceX
Companies sign definitive agreement to merge with a newly formed subsidiary of NutraCea merging into RiceX, RiceX becoming a wholly owned subsidiary of NutraCea, and the shareholders of RiceX to receive shares of NutraCea common stock in exchange for RiceX shares.
- Whole Living Reports 2004 Year End Results
Company reports revenues for 2004 of $6,758,535 with a net loss of ($0.06) per share.
- Whole Living Reports 2004 Year End Results
Company reports revenues for 2004 of $6,758,535 with a net loss of ($0.06) per share.
- Neptune Technologies & Bioressources Inc. Reports Q3 Results
Company reports revenues of $1,292,460 compared to $601,576 prior year, with an EBITDA of $117,000 compared to a negative EBITDA of $240,000 in 2004.
- Neptune Technologies & Bioressources Inc. Reports Q3 Results
Company reports revenues of $1,292,460 compared to $601,576 prior year, with an EBITDA of $117,000 compared to a negative EBITDA of $240,000 in 2004.
- Chr. Hansen opens new office in Colombia
New premises is to be the cornerstone in the company’s aim to gain new market shares.
- Chr. Hansen opens new office in Colombia
New premises is to be the cornerstone in the company’s aim to gain new market shares.
- Chr. Hansen opens new office in Colombia
New premises is to be the cornerstone in the company’s aim to gain new market shares.
- Chr. Hansen opens new office in Colombia
New premises is to be the cornerstone in the company’s aim to gain new market shares.
- Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors
Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role.
- Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors
Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role.
- Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors
Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role.
- Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors
Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role.
- Technology Flavors & Fragrances, Inc. Enters into Definitive Merger Agreement
Company merging with FFG Industries, Inc.
- Technology Flavors & Fragrances, Inc. Enters into Definitive Merger Agreement
Company merging with FFG Industries, Inc.
- Cargill and Diversa Sign Collaboration for Development of Novel Enzymes
Companies to collaborate to discover and develop novel enzymes for the cost- effective production of a proprietary product.
- Cargill and Diversa Sign Collaboration for Development of Novel Enzymes
Companies to collaborate to discover and develop novel enzymes for the cost- effective production of a proprietary product.
- Fonterra Ends National Foods Offer and Divests Stake
Fonterra announces it intends to withdraw onw offer and accept San Miguel Corporation’s offer of $6.40 per share, if that offer is unconditional.
- Fonterra Ends National Foods Offer and Divests Stake
Fonterra announces it intends to withdraw onw offer and accept San Miguel Corporation’s offer of $6.40 per share, if that offer is unconditional.
- New Morning Corporation Appoints New Management and Director
Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director.
- New Morning Corporation Appoints New Management and Director
Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director.
- New Morning Corporation Appoints New Management and Director
Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director.
- New Morning Corporation Appoints New Management and Director
Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director.
- VitaCube Completes Financing
Company has closed its offer of 1,500,000 units at $6.15 per unit for gross proceeds of $9,225,000,led by The Shemano Group, S.W. Bach & Company and Neidiger Tucker Bruner, Inc.
- VitaCube Completes Financing
Company has closed its offer of 1,500,000 units at $6.15 per unit for gross proceeds of $9,225,000,led by The Shemano Group, S.W. Bach & Company and Neidiger Tucker Bruner, Inc.
- John L. Cassis Joins Nutrition 21 Board Of Directors
Company announces that John L. Cassis has joined the Company's Board of Directors, succeeding Robert Pollack.
- John L. Cassis Joins Nutrition 21 Board Of Directors
Company announces that John L. Cassis has joined the Company's Board of Directors, succeeding Robert Pollack.
- John L. Cassis Joins Nutrition 21 Board Of Directors
Company announces that John L. Cassis has joined the Company's Board of Directors, succeeding Robert Pollack.
- John L. Cassis Joins Nutrition 21 Board Of Directors
Company announces that John L. Cassis has joined the Company's Board of Directors, succeeding Robert Pollack.
- Renaissance-Glykon HCA Agreement in Force
Company has confirmed that exclusive licensing agreement with Glykon Technologies Group, LLC is in full force.
- Renaissance-Glykon HCA Agreement in Force
Company has confirmed that exclusive licensing agreement with Glykon Technologies Group, LLC is in full force.
- Phosphagenics Ltd and Swisse Vitamins Pty Ltd reach agreement for Vitamin E phosphate
Company signs deal to supply Vitamin E phosphate to Australian company Swisse Vitamins Pty Ltd.
- Phosphagenics Ltd and Swisse Vitamins Pty Ltd reach agreement for Vitamin E phosphate
Company signs deal to supply Vitamin E phosphate to Australian company Swisse Vitamins Pty Ltd.
- DSM Sells Bakery Ingredients Business to Gilde
Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa.
- DSM Sells Bakery Ingredients Business to Gilde
Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa.
- DSM Sells Bakery Ingredients Business to Gilde
Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa.
- DSM Sells Bakery Ingredients Business to Gilde
Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa.
- DSM Sells Bakery Ingredients Business to Gilde
Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa.
- DSM Sells Bakery Ingredients Business to Gilde
Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa.
- DSM Sells Bakery Ingredients Business to Gilde
Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa.
- Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division
Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division.
- Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division
Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division.
- Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division
Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division.
- Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division
Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division.
- CAROTECH BHD - Enroute to IPO on the Malaysian MESDAQ
Company announces its initial public offering of 76,690,000 shares RM0.40 each. The listing is expected to raise RM30.7 million that will be used to repay borrowings and for working capital.
- CAROTECH BHD - Enroute to IPO on the Malaysian MESDAQ
Company announces its initial public offering of 76,690,000 shares RM0.40 each. The listing is expected to raise RM30.7 million that will be used to repay borrowings and for working capital.
- CoolBrands reports operating results for second quarter of fiscal 2005
Company reports revenues in the quarter were $87,549,000, down 17.0% from the prior year, with a net loss of ($3,973,000), ($0.07 per basic and diluted share), compared with net earnings of $9,475,000 ($0.17 per basic and diluted share) prior year.
- CoolBrands reports operating results for second quarter of fiscal 2005
Company reports revenues in the quarter were $87,549,000, down 17.0% from the prior year, with a net loss of ($3,973,000), ($0.07 per basic and diluted share), compared with net earnings of $9,475,000 ($0.17 per basic and diluted share) prior year.
- PacificHealth Laboratories, Inc. Reports Year End and Fourth Quarter 2004 Results
Company reports 2004 revenues of $6,807,271, compared to $5,453,571 prior year, reporting a net loss of ($2,521,096), or ($0.25) per share for the year compared to a net loss of ($1,451,274), or ($0.20) per share for 2003.
- PacificHealth Laboratories, Inc. Reports Year End and Fourth Quarter 2004 Results
Company reports 2004 revenues of $6,807,271, compared to $5,453,571 prior year, reporting a net loss of ($2,521,096), or ($0.25) per share for the year compared to a net loss of ($1,451,274), or ($0.20) per share for 2003.
- NutraCea Enters Into Strategic Relationship With W. F. Young, Inc.
Company's largest customer, W. F. Young, Inc., has made a strategic investment in NutraCea which will result in NutraCea obtaining the exclusive manufacturing rights for existing and new Stabilized Rice Bran Products.
- NutraCea Enters Into Strategic Relationship With W. F. Young, Inc.
Company's largest customer, W. F. Young, Inc., has made a strategic investment in NutraCea which will result in NutraCea obtaining the exclusive manufacturing rights for existing and new Stabilized Rice Bran Products.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
SAN DIEGO, CA, APRIL 11, 2005 – Imagenetix, Inc., (OTCBB: IAGX – News), www.imagenetix.net, the developer of Celadrin, a natural compound for joint health, announced today that it has formed a partnership with Cymbiotics, Inc., located here, and Dr. Reddy’s Laboratories, (RDY), a major pharmaceutical company in Hyderabad, India, to launch Celadrin as a pharmaceutical in India. Celadrin has been approved for use as a drug in India to help reduce pain and inflammation in patients with joint conditions. In the United States, Celadrin is currently available as a dietary supplement at food, drug and mass retail stores.
According to Satish Reddy, Managing Director and COO of Dr. Reddy’s, “Dr. Reddy’s is emerging as the partner of choice for many innovators in healthcare because of our strong brand equity and extensive reach in the Indian market. Celadrin will enhance the treatment options available to medical practitioners in India, and we will be marketing the product in capsule and topical cream forms.”
Celadrin has been shown to be safe and effective in several double-blind, placebo-controlled clinical studies. In one such study conducted at the University of Connecticut, patients with knee joint conditions who used Celadrin in cream form showed significant improvement in quality of life measurements such as getting up from a seated position and stair climbing. A similar study determined that patients who took Celadrin orally improved knee range of motion and overall function. Both studies were published in the Journal of Rheumatology.
San Diego based Imagenetix, Inc. (Symbol: IAGX), www.imagenetix.net, is an innovator of scientifically tested, natural-based, proprietary bio-ceutical products that enhance human health. The company develops, formulates and private-labels, proprietary over-the-counter topical creams, skin care products and nutritional supplements to be marketed globally through multiple channels of distribution.
Dr. Reddy’s Laboratories (NYSE: RDY) , www.drreddys.com, is a global, vertically integrated pharmaceutical company with a presence across the value chain, producing and delivering safe, innovative, and high quality finished dosage forms, active pharmaceutical ingredients and biotechnology products which are marketed in more than 100 countries.
Cymbiotics, Inc., based in San Diego, CA (USA), is a bio-pharmaceutical company that designs, develops, validates and introduces innovative disease-specific formulations in pain management, cardiovascular disease, periodontal disease, urinary incontinence and other inflammation management-related conditions. For more information, visit www.cymbiotics.net.
###
|